 | AbCellera Biologics Inc. | |||
| NMS : ABCL || Location: Canada | ||||
$3.91-0.01 (-0.26%) |
0.77 M | 3.84 - 3.97 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 23.591 M |
| March 15, 2024 | 23.039 M |
| Feb. 29, 2024 | 22.785 M |
| Feb. 15, 2024 | 22.814 M |
| Jan. 31, 2024 | 24.489 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.13 | -0.17 | -26.02% |
| 09/30/2023 | -0.14 | -0.10 | 27.06% |
| 06/30/2023 | -0.13 | -0.11 | 17.04% |
| 03/31/2023 | -0.14 | -0.14 | -1.16% |
| 12/31/2022 | -0.01 | -0.10 | -1751.85% |
ABCL Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 292.782M | Shares Float | 191.758M |
| Short Float | 23.591M | Market Cap | 1147.71M |
| Institution ownership | 43.65% | Insider ownership | 28.089% |
| Earnings Date | 05/07/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.51 | Forward EPS | -0.69 |